A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection

Evolution

Volumn 65, Issue 11, 2011, Pages 3311-3322

  Cagliani, Rachele ^a   Riva, Stefania ^a   Fumagalli, Matteo ^a   Biasin, Mara ^b   Caputo, Sergio Lo ^c   Mazzotta, Francesco ^c   Piacentini, Luca ^b   Pozzoli, Uberto ^a   Bresolin, Nereo ^a,d   Clerici, Mario ^b,e   Sironi, Manuela ^a  

^a SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

APOBEC3H; Cytidine deaminase genes; Haplotype; HIV 1 infection; Positive selection

Indexed keywords

APOBEC3H PROTEIN, HUMAN; HYDROLASE;

ALLELE; DISEASE RESISTANCE; EVOLUTIONARY BIOLOGY; GENETIC DIFFERENTIATION; GENETIC VARIATION; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHESIS TESTING; INFECTIOUS DISEASE; NATURAL SELECTION; PROTEIN; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASE;

ARTICLE; DISEASE RESISTANCE; DNA SEQUENCE; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ITALY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS;

AMINOHYDROLASES; BASE SEQUENCE; DISEASE RESISTANCE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES;

EID: 80054901877     PISSN: 00143820     EISSN: 15585646     Source Type: Journal    
DOI: 10.1111/j.1558-5646.2011.01368.x     Document Type: Article

References (49)

1. An, P., G. Bleiber, P. Duggal, G. Nelson, M. May, B. Mangeat, I. Alobwede, D. Trono, D. Vlahov, S. Donfield, et al. 2004. APOBEC3G genetic variants and their influence on the progression to AIDS. J. Virol. 78:11070-11076.
2. Bamshad, M. J., S. Mummidi, E. Gonzalez, S. S. Ahuja, D. M. Dunn, W. S. Watkins, S. Wooding, A. C. Stone, L. B. Jorde, R. B. Weiss, et al. 2002. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc. Natl. Acad. Sci. USA 99:10539-10544.
3. Bandelt, H. J., P. Forster, and A. Rohl 1999. Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol. 16:37-48.
4. Barreiro, L. B., M. Ben-Ali, H. Quach, G. Laval, E. Patin, J. K. Pickrell, C. Bouchier, M. Tichit, O. Neyrolles, B. Gicquel, et al. 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet. 5:e1000562.
5. Biasin, M., L. Piacentini, S. Lo Caputo, V. Naddeo, P. Pierotti, M. Borelli, D. Trabattoni, F. Mazzotta, G. M. Shearer, and M. Clerici 2010. TLR activation pathways in HIV-1-exposed seronegative individuals. J. Immunol. 184:2710-2717.
6. Biasin, M., L. Piacentini, S. Lo Caputo, Y. Kanari, G. Magri, D. Trabattoni, V. Naddeo, L. Lopalco, A. Clivio, E. Cesana, et al. 2007. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J. Infect. Dis. 195:960-964.
7. Cagliani, R., M. Fumagalli, M. Biasin, L. Piacentini, S. Riva, U. Pozzoli, M. C. Bonaglia, N. Bresolin, M. Clerici, and M. Sironi 2010a. Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum. Genet. 128:577-588.
8. Cagliani, R., S. Riva, M. Biasin, M. Fumagalli, U. Pozzoli, S. Lo Caputo, F. Mazzotta, L. Piacentini, N. Bresolin, M. Clerici, et al. 2010b. Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection. Hum. Mol. Genet. 19:4705-4714.
9. Charlesworth, D. 2006. Balancing selection and its effects on sequences in nearby genome regions. PLoS Genet. 2:e64.
10. Conticello, S. G. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9:229.
11. Cullen, B. R. 2006. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80:1067-1076.
12. Emerman, M., and H. S. Malik 2010. Paleovirology-modern consequences of ancient viruses. PLoS Biol. 8:e1000301.
13. Fu, Y. X., and W. H. Li 1993. Statistical tests of neutrality of mutations. Genetics 133:693-709.
14. Fumagalli, M., R. Cagliani, U. Pozzoli, S. Riva, G. P. Comi, G. Menozzi, N. Bresolin, and M. Sironi 2009. Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res. 19:199-212.
15. Gutenkunst, R. N., R. D. Hernandez, S. H. Williamson, and C. D. Bustamante 2009. Inferring the joint demographic history of multiple populations from multidimensional SNP frequency data. PLoS Genet. 5:e1000695.
16. Haynes, B. F., and R. J. Shattock 2008. Critical issues in mucosal immunity for HIV-1 vaccine development. J. Allergy Clin. Immunol. 122:3-9; quiz 10-11.
17. Johnson, W. E., and S. L. Sawyer 2009. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61:163-176.
18. Kanari, Y., M. Clerici, H. Abe, H. Kawabata, D. Trabattoni, S. L. Caputo, F. Mazzotta, H. Fujisawa, A. Niwa, C. Ishihara, et al. 2005. Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians. AIDS 19:1015-1024.
19. Karlin, S., and S. F. Altschul 1990. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl. Acad. Sci. USA 87:2264-2268.
20. Land, A. M., T. B. Ball, M. Luo, R. Pilon, P. Sandstrom, J. E. Embree, C. Wachihi, J. Kimani, and F. A. Plummer 2008. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya. J. Virol. 82:8172-8182.
21. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, et al.; International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
22. Li, M. M., L. I. Wu, and M. Emerman 2010a. The range of human APOBEC3H sensitivity to lentiviral Vif proteins. J. Virol. 84:88-95.
23. Li, M. M., L. I. Wu, and M. Emerman 2010b. The range of human APOBEC3H sensitivity to lentiviral Vif proteins. J. Virol. 84:88-95.
24. Marth, G. T., E. Czabarka, J. Murvai, and S. T. Sherry 2004. The allele frequency spectrum in genome-wide human variation data reveals signals of differential demographic history in three large world populations. Genetics 166:351-372.
25. Nei, M., and W. H. Li 1979. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc. Natl. Acad. Sci. USA 76:5269-5273.
26. OhAinle, M., J. A. Kerns, H. S. Malik, and M. Emerman 2006. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 80:3853-3862.
27. OhAinle, M., J. A. Kerns, M. M. Li, H. S. Malik, and M. Emerman 2008. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell. Host Microbe 4:249-259.
28. Olson, M. V. 1999. When less is more: gene loss as an engine of evolutionary change. Am. J. Hum. Genet. 64:18-23.
29. Ooms, M., S. Majdak, C. W. Seibert, A. Harari, and V. Simon 2010. The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity. J. Virol. 84:7961-7969.
30. Ortiz, M., N. Guex, E. Patin, O. Martin, I. Xenarios, A. Ciuffi, L. Quintana-Murci, and A. Telenti 2009. Evolutionary trajectories of primate genes involved in HIV pathogenesis. Mol. Biol. Evol. 26:2865-2875.
31. Piacentini, L., M. Biasin, C. Fenizia, and M. Clerici 2009. Genetic correlates of protection against HIV infection: the ally within. J. Intern. Med. 265:110-124.
32. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. de Bakker, M. J. Daly, and P. C. Sham 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-575.
33. Refsland, E. W., M. D. Stenglein, K. Shindo, J. S. Albin, W. L. Brown, and R. S. Harris 2010. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38:4274-4284.
34. Ross, S. R. 2009. Are viruses inhibited by APOBEC3 molecules from their host species PLoS Pathog. 5:e1000347.
35. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
36. Sawyer, S. 1989. Statistical tests for detecting gene conversion. Mol. Biol. Evol. 6:526-538.
37. Sawyer, S. L., M. Emerman, and H. S. Malik 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2:E275.
38. Schaffner, S. F., C. Foo, S. Gabriel, D. Reich, M. J. Daly, and D. Altshuler 2005. Calibrating a coalescent simulation of human genome sequence variation. Genome Res. 15:1576-1583.
39. Stephens, M., and P. Scheet 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76:449-462.
40. Stephens, M., N. J. Smith, and P. Donnelly 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68:978-989.
41. Tajima, F. 1989. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595.
42. Thornton, K. 2003. Libsequence: a C++ class library for evolutionary genetic analysis. Bioinformatics 19:2325-2327.
43. Ulenga, N. K., A. D. Sarr, S. Thakore-Meloni, J. L. Sankale, G. Eisen, and P. J. Kanki 2008. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. J. Infect. Dis. 198:486-492.
44. Voight, B. F., A. M. Adams, L. A. Frisse, Y. Qian, R. R. Hudson, and A. Di Rienzo 2005. Interrogating multiple aspects of variation in a full resequencing data set to infer human population size changes. Proc. Natl. Acad. Sci. USA 102:18508-18513.
45. Watterson, G. A. 1975. On the number of segregating sites in genetical models without recombination. Theor. Popul. Biol. 7:256-276.
46. Wright, S. 1950. Genetical structure of populations. Nature 166:247-249.
47. Wright, S. I., and B. Charlesworth 2004. The HKA test revisited: a maximum-likelihood-ratio test of the standard neutral model. Genetics 168:1071-1076.
48. Zhang, J., and D. M. Webb 2004. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet. 13:1785-1791.
49. Zhen, A., T. Wang, K. Zhao, Y. Xiong, and X. F. Yu 2010. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J. Virol. 84:1902-1911.